150 related articles for article (PubMed ID: 22338054)
1. CD138 (syndecan-1) expression in bone-forming tumors.
Nunez AL; Siegal GP; Reddy VV; Wei S
Am J Clin Pathol; 2012 Mar; 137(3):423-8. PubMed ID: 22338054
[TBL] [Abstract][Full Text] [Related]
2. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
[TBL] [Abstract][Full Text] [Related]
3. Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors.
Sulzbacher I; Birner P; Trieb K; Lang S; Chott A
Virchows Arch; 2002 Oct; 441(4):345-9. PubMed ID: 12404059
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma.
Gomez-Brouchet A; Mourcin F; Gourraud PA; Bouvier C; De Pinieux G; Le Guelec S; Brousset P; Delisle MB; Schiff C
Hum Pathol; 2010 Sep; 41(9):1220-30. PubMed ID: 20399482
[TBL] [Abstract][Full Text] [Related]
5. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms.
O'Connell FP; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2004 Feb; 121(2):254-63. PubMed ID: 14983940
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
[TBL] [Abstract][Full Text] [Related]
7. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.
Conner JR; Hornick JL
Histopathology; 2013 Jul; 63(1):36-49. PubMed ID: 23701429
[TBL] [Abstract][Full Text] [Related]
8. FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic Tool.
Amary F; Markert E; Berisha F; Ye H; Gerrand C; Cool P; Tirabosco R; Lindsay D; Pillay N; O'Donnell P; Baumhoer D; Flanagan AM
Am J Surg Pathol; 2019 Dec; 43(12):1661-1667. PubMed ID: 31490237
[TBL] [Abstract][Full Text] [Related]
9. Osteogenic tumors of bone.
Green JT; Mills AM
Semin Diagn Pathol; 2014 Jan; 31(1):21-9. PubMed ID: 24680179
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of N-cadherin and β-catenin protein in osteosarcoma].
Yang JZ; Zhang XH; Liu JR; Ding Y; Gao F; Wang Y
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):586-9. PubMed ID: 21122409
[TBL] [Abstract][Full Text] [Related]
11. Fine needle aspiration of bone tumors.
Agarwal S; Agarwal T; Agarwal R; Agarwal PK; Jain UK
Cancer Detect Prev; 2000; 24(6):602-9. PubMed ID: 11198274
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin synthesis by osteoid osteoma and osteoblastoma.
Wold LE; Pritchard DJ; Bergert J; Wilson DM
Mod Pathol; 1988 Mar; 1(2):129-31. PubMed ID: 3266336
[TBL] [Abstract][Full Text] [Related]
13. Osteoid osteoma and osteoblastoma: novel histological and immunohistochemical observations as evidence for a single entity.
Barlow E; Davies AM; Cool WP; Barlow D; Mangham DC
J Clin Pathol; 2013 Sep; 66(9):768-74. PubMed ID: 23814261
[TBL] [Abstract][Full Text] [Related]
14. [Primary bone and joint tumor--statistical analysis of 571 cases].
Yang DZ; Wu X
Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):51-4. PubMed ID: 3015534
[TBL] [Abstract][Full Text] [Related]
15. [Osteoid-forming bone tumors : Morphology and current translational cell biology].
Roessner A; Schoeder V; Smolle M; Haybäck J
Pathologe; 2020 Mar; 41(2):123-133. PubMed ID: 32078700
[TBL] [Abstract][Full Text] [Related]
16. P63 expression as a biomarker discriminating giant cell tumor of bone from other giant cell-rich bone lesions.
Shooshtarizadeh T; Rahimi M; Movahedinia S
Pathol Res Pract; 2016 Oct; 212(10):876-879. PubMed ID: 27473669
[TBL] [Abstract][Full Text] [Related]
17. [Gene profiling of MAPK pathway in human osteosarcoma].
Li GD; Cai ZD; Zhang YQ; Gong HY; Tang H; Zhang QL
Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):340-5. PubMed ID: 19799081
[TBL] [Abstract][Full Text] [Related]
18. Role of immunohistochemical cyclo-oxygenase-2 (COX-2) and osteocalcin in differentiating between osteoblastomas and osteosarcomas.
El-Badawi ZH; Muhammad EM; Noaman HH
Malays J Pathol; 2012 Jun; 34(1):15-23. PubMed ID: 22870593
[TBL] [Abstract][Full Text] [Related]
19. Osteoid-producing tumors of bone.
White LM; Kandel R
Semin Musculoskelet Radiol; 2000; 4(1):25-43. PubMed ID: 11061690
[TBL] [Abstract][Full Text] [Related]
20. Expression of bone morphogenetic proteins in giant cell tumor of bone.
Kudo N; Ogose A; Ariizumi T; Kawashima H; Hotta T; Hatano H; Morita T; Nagata M; Siki Y; Kawai A; Hotta Y; Hoshino M; Endo N
Anticancer Res; 2009 Jun; 29(6):2219-25. PubMed ID: 19528484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]